We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$300M
AUM Growth
-$5.12M
Cap. Flow
+$2.3M
Cap. Flow %
0.77%
Top 10 Hldgs %
11.57%
Holding
270
New
33
Increased
92
Reduced
83
Closed
33

Sector Composition

Rank Sector Weight
1 Financials 23.93%
2 Industrials 17.69%
3 Consumer Discretionary 11.11%
4 Technology 9.66%
5 Real Estate 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEI icon
201
Methode Electronics
MEI
$592M
$368K 0.12%
9,400
-1,450
-13% -$58.8K
RUTH
202
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$368K 0.12%
15,040
-2,280
-13% -$53.7K
SNA icon
203
Snap-on
SNA
$21.5B
$366K 0.12%
+2,480
New +$408K
VC icon
204
Visteon
VC
$2.78B
$363K 0.12%
3,290
-500
-13% -$62.5K
SCL icon
205
Stepan Co
SCL
$1.48B
$362K 0.12%
4,350
-700
-14% -$55.5K
ARRY
206
DELISTED
Array Biopharma Inc
ARRY
$361K 0.12%
22,090
-3,470
-14% -$55.6K
MZTI
207
The Marzetti Company
MZTI
$3.11B
$360K 0.12%
2,920
MANH icon
208
Manhattan Associates
MANH
$11.4B
$355K 0.12%
8,470
-1,380
-14% -$64.4K
SSTK icon
209
Shutterstock
SSTK
$219M
$355K 0.12%
7,370
-1,170
-14% -$55.2K
AEE icon
210
Ameren
AEE
$30.1B
$354K 0.12%
6,250
+2,050
+49% +$113K
AEIS icon
211
Advanced Energy
AEIS
$13B
$354K 0.12%
5,540
-840
-13% -$58K
ALK icon
212
Alaska Air
ALK
$5.58B
$340K 0.11%
5,490
CTMX icon
213
CytomX Therapeutics
CTMX
$754M
$336K 0.11%
11,820
-1,850
-14% -$52.8K
ANDV
214
DELISTED
Andeavor
ANDV
$332K 0.11%
3,300
+260
+9% +$27.1K
EXEL icon
215
Exelixis
EXEL
$13.4B
$328K 0.11%
14,830
PBI icon
216
Pitney Bowes
PBI
$2.39B
$326K 0.11%
29,920
-4,160
-12% -$51.5K
HOG icon
217
Harley-Davidson
HOG
$2.71B
$318K 0.11%
7,420
STMP
218
DELISTED
Stamps.com, Inc.
STMP
$314K 0.1%
1,560
-240
-13% -$47K
B
219
DELISTED
Barnes Group Inc.
B
$313K 0.1%
+5,230
New +$330K
CCXI
220
DELISTED
ChemoCentryx, Inc.
CCXI
$312K 0.1%
22,960
-3,778
-14% -$39K
ANIP icon
221
ANI Pharmaceuticals
ANIP
$1.78B
$311K 0.1%
5,340
-830
-13% -$52.7K
CBRL icon
222
Cracker Barrel
CBRL
$1.29B
$299K 0.1%
1,880
-300
-14% -$49.7K
MYOK
223
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$283K 0.09%
5,790
-870
-13% -$45.2K
CSOD
224
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$274K 0.09%
7,010
-1,080
-13% -$43.9K
LNTH icon
225
Lantheus
LNTH
$6.59B
$255K 0.09%
16,020
-2,590
-14% -$50.5K

Similar funds

Piermont Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Piermont Capital Management held 270 positions worth $300M, down 1.7% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Piermont Capital Management's Q1 2018 filing shows 33 new, 92 increased, 83 reduced and 33 closed positions. Its largest new stake was Electro Scientific Industries: 136,150 shares worth $2.63M. The largest sale was Sucampo Pharmaceuticals, Inc., an estimated $3.1M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Piermont Capital Management's largest Q1 2018 buy was Electro Scientific Industries: 136,150 shares worth $2.63M.
  • Piermont Capital Management added most to Meridian Bancorp, Inc. in Q1 2018, an estimated $1.67M increase.
  • Piermont Capital Management's biggest Q1 2018 reduction was Spire, cutting an estimated $2.64M.
  • Piermont Capital Management fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $3.1M.
  • Piermont Capital Management's ten largest holdings make up 12% of its $300M portfolio in Q1 2018.
  • Piermont Capital Management opened 33 new positions and closed 33 in Q1 2018.
  • Piermont Capital Management's portfolio value fell 1.7% quarter-over-quarter to $300M.

Based on Piermont Capital Management's 13F filing for Q1 2018, filed 9 May 2018.